- Home
- VFL vs ICAD Comparison
VFL vs ICAD Comparison
Compare VFL & ICAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VFL
- ICAD
- Stock Information
- Founded
- VFL 1993
- ICAD 1984
- Country
- VFL United States
- ICAD United States
- Employees
- VFL N/A
- ICAD N/A
- Industry
- VFL Finance/Investors Services
- ICAD Medical/Dental Instruments
- Sector
- VFL Finance
- ICAD Health Care
- Exchange
- VFL Nasdaq
- ICAD Nasdaq
- Market Cap
- VFL 117.3M
- ICAD 103.3M
- IPO Year
- VFL N/A
- ICAD 1986
- Fundamental
- Price
- VFL $9.73
- ICAD $3.76
- Analyst Decision
- VFL
- ICAD Hold
- Analyst Count
- VFL 0
- ICAD 1
- Target Price
- VFL N/A
- ICAD N/A
- AVG Volume (30 Days)
- VFL 38.0K
- ICAD 223.0K
- Earning Date
- VFL 01-01-0001
- ICAD 08-12-2025
- Dividend Yield
- VFL 4.16%
- ICAD N/A
- EPS Growth
- VFL N/A
- ICAD N/A
- EPS
- VFL N/A
- ICAD N/A
- Revenue
- VFL N/A
- ICAD $19,528,000.00
- Revenue This Year
- VFL N/A
- ICAD $3.60
- Revenue Next Year
- VFL N/A
- ICAD N/A
- P/E Ratio
- VFL N/A
- ICAD N/A
- Revenue Growth
- VFL N/A
- ICAD 8.86
- 52 Week Low
- VFL $7.93
- ICAD $1.18
- 52 Week High
- VFL $10.77
- ICAD $4.02
- Technical
- Relative Strength Index (RSI)
- VFL 54.10
- ICAD 51.35
- Support Level
- VFL $9.60
- ICAD $3.66
- Resistance Level
- VFL $9.85
- ICAD $3.92
- Average True Range (ATR)
- VFL 0.07
- ICAD 0.13
- MACD
- VFL 0.02
- ICAD -0.02
- Stochastic Oscillator
- VFL 64.00
- ICAD 52.94
About VFL abrdn National Municipal Income Fund
Delaware Investments Natl Muni Income is a closed-end investment fund. The Fund seeks to provide current income exempt from regular federal income tax consistent with the preservation of capital. The company's product portfolio includes Mutual funds, Exchange-traded funds, Private markets, Delaware Funds by Macquarie Premier Models, Managed accounts, Closed-end funds, and Variable Insurance Products.
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment includes image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.